This content is only available within our institutional offering.

17 Apr 2025
Q125 sales and 15 questions for management

Sign in
This content is only available to commercial clients. Sign in if you have access or contact support@research-tree.com to set up a commercial account
This content is only available to commercial clients. Sign in if you have access or contact support@research-tree.com to set up a commercial account
Q125 sales and 15 questions for management
- Published:
17 Apr 2025 -
Author:
Omanadze Mikheil MO | Stent Jeff JS | Queulvee Camille CQ -
Pages:
15 -
Summary of Q125 sales
While LFL sales growth of +3.5% was materially ahead of Bloomberg consensus (+1.3%) this included an unexpected net +EUR100m benefit from IT transformations when a EUR(130)m impact was expected. Adjusting both reported LFL and Bloomberg consensus LFL for IT transformation impacts, we estimate that LFL sales growth would have been +2.6% and Bloomberg consensus would have been +2.5%. In other words, on an underlying basis, growth was broadly in-line (albeit buyside consensus was likely lower post recent peer reporting).
News
We highlight that L''Oreal estimates that the beauty market grew at close to +2% in Q1.
Earnings
We revise our FY25e/FY26e/FY27e EPS by (1)%.
Investment thesis
We see downside to the valuation as the market gradually shifts to our view that L''Oreal likely has a c.5% mid-term organic sales growth profile.
Rating / target price
We maintain our Underperform rating and EUR300 target price.
15 questions for management
The market grew at close to 2% in Q1 and you expect around 4% for the full year, can you please explain what will drive this strong acceleration?